Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01704459
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
T4B | A | 2NNQ | 0.82 | ||
I3N | 1-BENZYL-5-METHOXY-2-METHYL-1H- INDOL-3-YL)-ACETIC ACID | A | 1DCY | 0.73 | |
6IN | 4-(1-BENZYL-3-CARBAMOYLMETHYL-2- METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID | A | 1DB5 | 0.72 | |
001 | 1-[2,2-DIFLUORO-2-(3,4,5-TRIMETHOXY- PHENYL)-ACETYL]-PIPERIDINE-2-CARBOXYLIC ACID 4- PHENYL-1-(3-PYRIDIN-3-YL-PROPYL)- BUTYL ESTER | A,B,D | 1J4R | 0.72 | |
J80 | (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE | 1,4 | 1VBB | 0.74 | |
J80 | (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE | 1,4 | 1PO1 | 0.74 | |
EI1 | 3-ETHYL-2-(4-HYDROXYPHENYL)-2H- INDAZOL-5-OL | A,B | 2QAB | 0.72 | |
346 | (R)-(4-CARBAMIMIDOYL-PHENYLAMINO)- [5-ETHOXY-2-FLUORO-3-[(R)-TETRAHYDRO- FURAN-3-YLOXY]-PHENYL]-ACETIC ACID | H | 2BZ6 | 0.71 | |
4BC | 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL- 2,4-DIHYDROXYPHENYL)-2H-PYRAZOLE- 3-CARBOXYLIC ACID | A | 1YC3 | 0.71 | |
4BC | 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL- 2,4-DIHYDROXYPHENYL)-2H-PYRAZOLE- 3-CARBOXYLIC ACID | A | 1YC1 | 0.71 | |
380 | (2R)-2-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO)- N-BENZYL-2-(3,4-DIMETHOXYPHENYL)ACETAMIDE | H,L | 1W2K | 0.7 | |
PQB | [5-AMINO-1-(4-FLUOROPHENYL)-1H- PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE | A | 2BAQ | 0.7 | |
PQB | [5-AMINO-1-(4-FLUOROPHENYL)-1H- PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE | A | 2GFS | 0.7 | |
R04 | (2E)-N-ALLYL-4-{[3-(4-BROMOPHENYL)- 5-FLUORO-1-METHYL-1H-INDAZOL-6- YL]OXY}-N-METHYL-2-BUTEN-1-AMINE | A,B,C | 1H3A | 0.71 | |
J78 | (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE | 1,4 | 1VBE | 0.73 | |
J78 | (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE | 1,4 | 1VBA | 0.73 | |
J78 | (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE | 1,4 | 1VBD | 0.73 | |
CT5 | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)-3-METHYL-1H-PYRAZOL-5-YL]- 6-ETHYLBENZENE-1,3-DIOL | A | 2BRC | 0.72 | |
CT5 | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)-3-METHYL-1H-PYRAZOL-5-YL]- 6-ETHYLBENZENE-1,3-DIOL | A,B | 2CDD | 0.72 | |
CT5 | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)-3-METHYL-1H-PYRAZOL-5-YL]- 6-ETHYLBENZENE-1,3-DIOL | A,B | 2BT0 | 0.72 | |
J77 | (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE | 1,4 | 1PO2 | 0.74 | |
J77 | (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE | 1,4 | 1VBC | 0.74 | |
241 | (2S)-2-(3-{[1-(4-METHOXYBENZOYL)- 2-METHYL-5-(TRIFLUOROMETHOXY)-1H- INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID | A,B | 2Q5P | 0.72 | |
240 | (2S)-2-(2-{[1-(4-METHOXYBENZOYL)- 2-METHYL-5-(TRIFLUOROMETHOXY)-1H- INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID | A,B | 2Q59 | 0.71 | |
ZAA | (5-{3-[2-(5-methyl-2-phenyl-1,3- oxazol-4-yl)ethoxy]benzyl}-2-phenyl- 2H-1,2,3-triazol-4-yl)acetic acid | A | 3BC5 | 0.71 | |
4DE | 1-(4-METHOXYPHENYL)-3,5-DIMETHYL- 1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | A,B | 1Y2D | 0.78 | |
R03 | ALLYL-{6-[3-(4-BROMO-PHENYL)-1- METHYL-1H-INDAZOL-6-YL]OXY}HEXYL)- N-METHYLAMINE | A,B,C | 1H39 | 0.72 | |
IMM | 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE- 3-ACETIC ACID | A,B | 1PGF | 0.71 | |
IMM | 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE- 3-ACETIC ACID | A,B | 1PGG | 0.71 | |
JK1 | 3-{4-[(phenylcarbamoyl)amino]-1H- pyrazol-1-yl}-N-(3,4,5-trimethoxyphenyl)benzamide | A | 3FI2 | 0.72 | |
JK2 | 3-{5-[(2-fluorophenyl)amino]-1H- indazol-1-yl}-N-(3,4,5-trimethoxyphenyl)benzamide | A | 3FI3 | 0.72 |